Delivery Order SPE2DX22D0029-SPE2D826F15EA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,908.34 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, which is non-set-aside and competitively awarded, operates under a firm fixed-price arrangement with an ultimate completion date of January 13, 2026. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $170,597.34 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and has an ultimate completion date of January 13, 2026. The delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $26,118.34 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026, with completion scheduled for January 15, 2026. This competitively awarded contract carries no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $150,157.80 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 20, 2026. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,529.10 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 15, 2026, and was competitively awarded with no set-aside designation. This award represents a task order issued under Amerisourcebergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,744.34 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, competitively awarded delivery order is a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,572.48 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025. This firm fixed price delivery order, with an ultimate completion date of December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $92,138.57 on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract, issued under a firm fixed-price arrangement with no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying pharmaceutical products and medical commodities to...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F15EADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,209.68 on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of its parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031. The company's federal contract portfolio demonstrates its critical role in supplying essential pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Medical Supply Chain has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in federal military medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 1/22/26 |